ADHD Medication Shortage: What to Do If Your Pharmacy Is Out

If your pharmacy cannot fill your ADHD prescription, do not stretch, skip or split doses on your own. Ask the pharmacist which strengths and manufacturers they can get and when, call a few other pharmacies, and then contact your prescriber with what you found, so they can send a new prescription to a pharmacy that has stock or adjust the plan safely.

This is still a live problem in late 2026. As of 26 October 2026, the FDA Drug Shortages database lists five stimulant products as currently in shortage: immediate-release mixed amphetamine salts tablets, lisdexamfetamine capsules, lisdexamfetamine chewable tablets, extended-release methylphenidate tablets and an extended-release methylphenidate film. The rest of this article explains what those listings mean, why controlled-substance rules make a shortage harder to work around, and how to get through one with as little disruption as possible.

What the FDA shortage list says right now

The FDA's database is the official public record of drug shortages, and most of its information comes from manufacturers. Each entry lists the companies that make the product, which strengths each one reports as available, limited or unavailable, and the reason for any gap. A product can be listed as "in shortage" even when several manufacturers report some strengths as available, because the FDA tracks whether supply meets national demand, not your local shelf.

Two practical points follow. First, an "available" note for a manufacturer does not mean your pharmacy's wholesaler carries it. Second, the list changes often: several manufacturers updated their entries in October 2026 alone. Check the FDA Drug Shortages database yourself before a refill is due rather than relying on news articles, which go out of date quickly.

Why stimulant shortages are harder to fix

Stimulants such as amphetamine, lisdexamfetamine and methylphenidate are Schedule II controlled substances, so the Drug Enforcement Administration (DEA) sets yearly limits on how much of each can be produced in the United States, called aggregate production quotas. Manufacturers cannot simply run extra batches when demand rises.

The DEA can raise a quota mid-year. In September 2025 it raised the 2025 quota for lisdexamfetamine and for the d-amphetamine used to make it, citing manufacturer reports of a domestic shortage of lisdexamfetamine capsules and chewable tablets caused by a shortage of an active ingredient. In October 2026, a proposed adjustment to the 2026 quotas for d,l-amphetamine, d-amphetamine and methylphenidate was received for federal regulatory review; as of today it is listed as pending. Quota increases take time to turn into tablets on pharmacy shelves, which is one reason shortages can outlast the headlines.

Step by step: what to do when your pharmacy is out

1. Start early. Ask for your refill several days before you run out, because a pharmacy may need a day or two to order, and a new prescription may need to be sent elsewhere.
2. Ask the pharmacist specific questions: which strengths of your exact medication they can get, from which manufacturers, and the expected date. Ask whether a different strength that adds up to your dose is in stock (for example, two lower-strength tablets), but do not accept that change without your prescriber's approval, since it requires a new prescription.
3. Call other pharmacies. Independent pharmacies and chains may order from different suppliers, so one being out does not mean all are. A pharmacy may not discuss controlled-substance stock in detail by phone, but you can ask whether it could fill a prescription for your medication and strength.
4. Ask about a partial fill. Federal law allows a Schedule II prescription to be partially filled at the patient's or prescriber's request, with the remaining portions filled no later than 30 days after the prescription was written, if state law does not prohibit it. Ask the pharmacist whether they can partially fill now and complete the rest later.
5. Contact your prescriber with what you learned: the pharmacy that has stock, its address, and which strengths are available. That turns a vague "it's out" into a quick decision.
6. Keep a written log of dates, pharmacies called and what each said. It helps your prescriber and any appeal to your insurer if a different product needs approval.

Moving a prescription to another pharmacy

It helps to know one rule before you start: under federal law, a prescription for a Schedule II controlled substance cannot be refilled. Each fill of a stimulant needs its own prescription, which is why a shortage usually means a new prescription rather than a simple "refill somewhere else."

New York generally requires prescriptions to be issued electronically, with narrow exceptions such as a temporary technological failure. That means you usually cannot carry a paper stimulant prescription from pharmacy to pharmacy.

Since 28 August 2023, a federal DEA rule has allowed an electronic Schedule II-V prescription that has not yet been filled to be transferred once to another pharmacy for its initial filling, at the patient's request, pharmacist to pharmacist, and only if state law allows it. Whether a particular pharmacy will do this depends on its systems and on state rules, so ask the pharmacist. If a transfer is not possible, the usual route is for your prescriber to cancel the original prescription and send a new one to the pharmacy that has stock. Tell the first pharmacy too, so the original is not filled later by mistake.

New York also limits most controlled-substance prescriptions to a 30-day supply, with exceptions for conditions the Health Commissioner has listed in regulations, and it restricts issuing a new prescription within 30 days until all but a 7-day supply of the previous one is used. Those rules affect how early a replacement prescription can be written, so contact your prescriber as soon as you know there is a problem rather than on the last day.

Alternatives your prescriber may consider

When one product is unavailable, a prescriber has several options. Which one makes sense depends on your history, what is actually in stock nearby, your insurance, and how you responded to past medications.

The comparisons in methylphenidate vs amphetamine and Concerta vs Ritalin vs Focalin explain how these products differ, which is useful background before that conversation. A change in product can also trigger an insurance prior authorization, so ask your prescriber and pharmacist to check coverage before the new prescription is sent.

If the only stock is a different generic

For most medications, switching manufacturers is uneventful. Extended-release methylphenidate is a cautionary example of why it is still worth paying attention. In November 2014 the FDA changed the rating of two generic versions of Concerta, made by Mallinckrodt and Kudco, from "AB" (therapeutically equivalent) to "BX," after adverse event reports, a review of earlier data and FDA laboratory testing suggested they might deliver the drug more slowly in the 7- to 12-hour range. The FDA said those products remained approved but were no longer recommended for automatic substitution, and advised patients with concerns to ask the pharmacy which manufacturer made their tablets and to talk with their prescriber rather than change treatment on their own. If a shortage forces a change of manufacturer and the medication seems to wear off earlier, write down the manufacturer name on the bottle label and the times you notice the difference, and bring both to your prescriber.

Why you should not ration on your own

Skipping days, taking half doses or saving tablets for "important" days can feel like a sensible way to stretch a short supply. The problem is that it changes your treatment without anyone tracking the effects, and it makes your next visit harder to interpret: your prescriber cannot tell whether symptoms reflect the medication, the dose or the gaps. Some extended-release tablets also must not be split or crushed; the Concerta label, for example, says splitting, crushing or chewing compromises its extended-release characteristics. If you are running low, tell your prescriber how many doses you have left; they can decide whether a temporary change in schedule is reasonable for you. If you are thinking about suicide or are in crisis, call or text 988 (the 988 Suicide & Crisis Lifeline) or go to the nearest emergency room.

Never take a stimulant prescribed to someone else, and do not buy ADHD medication from websites or social media sellers that do not require a valid prescription. Stimulant labels such as Vyvanse's carry a boxed warning about abuse, misuse and addiction, and stress safe storage and that the medicine should not be given to anyone else.

If you notice side effects after a switch, such as a faster heartbeat, chest discomfort, or trouble sleeping, report them. The article on ADHD medication and your heart explains which symptoms need prompt attention.

Telehealth prescriptions during a shortage

Many people with ADHD receive stimulant prescriptions through telehealth visits. Under a joint DEA and HHS rule, the federal telemedicine flexibilities that let DEA-registered practitioners prescribe controlled medications by telemedicine without a prior in-person visit run through 31 December 2026. Permanent rules have not been finalized, so the rules after that date may change. If you see your prescriber only by video, ask now how they will handle prescriptions after the current flexibilities end, especially if a shortage forces a change of medication around that time. Seeing Dr. Lewis by telehealth covers the location rules that apply to this practice.

A checklist to keep

If you are also weighing cost, lowering prescription costs covers discount programs and generics. If you are changing prescribers in the middle of a shortage, switching psychiatrists without a gap explains how to avoid running out during the handoff.

When a shortage is a reason to revisit the plan

A long shortage is sometimes a good moment to review the whole treatment plan rather than chase the same product every month. If your medication was only partly helping, or side effects were a problem, a planned change may be better than a forced one. The practice's article on when ADHD medication stops working covers related reasons to reassess.

At this practice, ADHD treatment plans may include lifestyle changes, nutrition and supplements, psychotherapy, executive-function coaching and medication when appropriate, and ongoing care includes psychiatric evaluation and medication management. Current patients should contact their prescriber through the practice as soon as a pharmacy reports a problem. If you are looking for a new prescriber, the medication management page and the guide to choosing psychiatric care explain how care starts.

Frequently asked questions

Is there still an Adderall shortage in 2026?

Yes. As of 26 October 2026 the FDA Drug Shortages database lists immediate-release mixed amphetamine salts tablets as currently in shortage, along with lisdexamfetamine and two extended-release methylphenidate products. Availability varies by strength and manufacturer, so ask your pharmacy about your exact product.

Can my pharmacist just give me a different strength or brand?

A pharmacist can often fill the same medication from a different manufacturer. Changing the strength, form or medication requires a new prescription from your prescriber with new directions.

Can I get an early refill to build a backup supply?

Generally no. Federal law does not allow Schedule II prescriptions to be refilled, and New York limits how soon a new controlled-substance prescription can be issued after the last one. Ask your prescriber what is possible for your situation.

Is it safe to switch from brand Concerta to a generic?

Many people switch without problems. In 2014 the FDA questioned whether two specific generic versions released medication the same way, so if you notice a change after a switch, tell your prescriber and ask the pharmacist which manufacturer you received.

What if I run out completely?

Contact your prescriber as soon as you know, rather than waiting. They can advise you on what to expect and how to restart when you get the medication. If you have chest pain, fainting or a racing heart, seek urgent medical care.

Should I order ADHD medication online from overseas?

No. Websites that sell stimulants without a valid prescription may ship counterfeit or contaminated products, and buying controlled substances that way is illegal. Work with your prescriber and a licensed pharmacy.

Sources

1. Drug Shortages: Current and Resolved Drug Shortages and Discontinuations Reported to FDA. U.S. Food and Drug Administration, 2026. accessdata.fda.gov
2. Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet: shortage detail. U.S. Food and Drug Administration, 2026. accessdata.fda.gov
3. Lisdexamfetamine Dimesylate Capsule: shortage detail. U.S. Food and Drug Administration, 2026. accessdata.fda.gov
4. Methylphenidate Hydrochloride Tablet, Extended Release and Methylphenidate Film, Extended Release: shortage details. U.S. Food and Drug Administration, 2026. accessdata.fda.gov
5. Drug Shortages. U.S. Food and Drug Administration, 2026. fda.gov
6. Adjustment to the 2025 Aggregate Production Quota for Lisdexamfetamine and d-Amphetamine (for conversion). Drug Enforcement Administration, Federal Register 90 FR 45249 (FR Doc. 2025-18110), 2025. govinfo.gov
7. Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for sale), Hydromorphone and Methylphenidate (for sale) Pursuant to 21 U.S.C. 826(h). OIRA, reginfo.gov (RIN 1117-ZA13), 2026. reginfo.gov
8. Transfer of Electronic Prescriptions for Schedules II-V Controlled Substances Between Pharmacies for Initial Filling (final rule). Drug Enforcement Administration, Federal Register 88 FR 48365, 2023. govinfo.gov
9. 21 U.S. Code § 829: Prescriptions (subsection (f), partial fills of schedule II controlled substances). Legal Information Institute, Cornell Law School, 2026. law.cornell.edu
10. New York Public Health Law § 3332: Prescribing; practitioners. New York State Senate, 2026. nysenate.gov
11. New York Public Health Law § 281: Electronic prescriptions. New York State Senate, 2026. nysenate.gov
12. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. DEA and HHS, Federal Register 90 FR 61301 (FR Doc. 2025-24123), 2025. govinfo.gov
13. Vyvanse (lisdexamfetamine dimesylate) prescribing information. Takeda Pharmaceuticals / DailyMed (NLM), 2026. dailymed.nlm.nih.gov
14. Adderall XR (mixed salts of a single-entity amphetamine product) prescribing information. Takeda Pharmaceuticals / DailyMed (NLM), 2026. dailymed.nlm.nih.gov
15. Mydayis (mixed salts of a single-entity amphetamine product) prescribing information. Takeda Pharmaceuticals / DailyMed (NLM), 2026. dailymed.nlm.nih.gov
16. Methylphenidate Hydrochloride Extended Release Tablets (generic Concerta) made by Mallinckrodt and Kudco. U.S. Food and Drug Administration, 2016. fda.gov
17. Concerta (methylphenidate hydrochloride) extended-release tablets prescribing information. Janssen Pharmaceuticals / DailyMed (NLM), 2026. dailymed.nlm.nih.gov

Educational information, not medical, tax or legal advice. Decisions about diagnosis, medication and treatment belong with a clinician who knows your history.